| FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular … C Cremolini, F Loupakis, C Antoniotti, C Lupi, E Sensi, S Lonardi, S Mezi, ... The Lancet Oncology 16 (13), 1306-1315, 2015 | 1161 | 2015 |
| Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer F Loupakis, C Cremolini, G Masi, S Lonardi, V Zagonel, L Salvatore, ... New England Journal of Medicine 371 (17), 1609-1618, 2014 | 1145 | 2014 |
| Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial C Aschele, L Cionini, S Lonardi, C Pinto, S Cordio, G Rosati, S Artale, ... Journal of clinical oncology 29 (20), 2773-2780, 2011 | 952 | 2011 |
| Cisplatin-versus carboplatin-based chemotherapy in first-line treatment of advanced non–small-cell lung cancer: an individual patient data meta-analysis A Ardizzoni, L Boni, M Tiseo, FV Fossella, JH Schiller, M Paesmans, ... Journal of the National Cancer Institute 99 (11), 847-857, 2007 | 855 | 2007 |
| Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a … L Del Mastro, L Boni, A Michelotti, T Gamucci, N Olmeo, S Gori, ... Jama 306 (3), 269-276, 2011 | 469 | 2011 |
| Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: a systematic … M Lambertini, HCF Moore, RCF Leonard, S Loibl, P Munster, M Bruzzone, ... Journal of clinical oncology 36 (19), 1981-1990, 2018 | 362 | 2018 |
| Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto … S Iliceto, D Scrutinio, P Bruzzi, G D'Ambrosio, L Boni, M Di Biase, ... Journal of the American College of Cardiology 26 (2), 380-387, 1995 | 307 | 1995 |
| Diagnostic accuracy of computed tomographic colonography for the detection of advanced neoplasia in individuals at increased risk of colorectal cancer D Regge, C Laudi, G Galatola, P Della Monica, L Bonelli, G Angelelli, ... Jama 301 (23), 2453-2461, 2009 | 294 | 2009 |
| Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy BJ Maron, P Spirito, MJ Ackerman, SA Casey, C Semsarian, NAM Estes, ... Journal of the American College of Cardiology 61 (14), 1527-1535, 2013 | 289 | 2013 |
| Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with … C Cremolini, C Antoniotti, D Rossini, S Lonardi, F Loupakis, F Pietrantonio, ... The Lancet Oncology 21 (4), 497-507, 2020 | 278 | 2020 |
| Expression of ΔNp73 is a molecular marker for adverse outcome in neuroblastoma patients I Casciano, K Mazzocco, L Boni, G Pagnan, B Banelli, G Allemanni, ... Cell Death & Differentiation 9 (3), 246-251, 2002 | 263 | 2002 |
| Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ... The Lancet Oncology 22 (11), 1507-1517, 2021 | 255 | 2021 |
| Ovarian suppression with triptorelin during adjuvant breast cancer chemotherapy and long-term ovarian function, pregnancies, and disease-free survival: a randomized clinical trial M Lambertini, L Boni, A Michelotti, T Gamucci, T Scotto, S Gori, ... Jama 314 (24), 2632-2640, 2015 | 235 | 2015 |
| Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma A Garaventa, R Luksch, MSL Piccolo, E Cavadini, PG Montaldo, ... Clinical Cancer Research 9 (6), 2032-2039, 2003 | 223 | 2003 |
| Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group … B De Bernardi, B Nicolas, L Boni, P Indolfi, M Carli, ... Journal of clinical oncology 21 (8), 1592-1601, 2003 | 204 | 2003 |
| Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial G Masi, L Salvatore, L Boni, F Loupakis, C Cremolini, L Fornaro, ... Annals of Oncology 26 (4), 724-730, 2015 | 200 | 2015 |
| Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results … C Cremolini, F Loupakis, C Antoniotti, S Lonardi, G Masi, L Salvatore, ... Annals of oncology 26 (6), 1188-1194, 2015 | 196 | 2015 |
| Randomized placebo controlled trial of low-dose tamoxifen to prevent local and contralateral recurrence in breast intraepithelial neoplasia A DeCensi, M Puntoni, A Guerrieri-Gonzaga, S Caviglia, F Avino, ... Journal of Clinical Oncology 37 (19), 1629-1637, 2019 | 188 | 2019 |
| The natural course of untreated sick sinus syndrome and identification of the variables predictive of unfavorable outcome C Menozzi, M Brignole, P Alboni, L Boni, N Paparella, G Gaggioli, G Lolli The American journal of cardiology 82 (10), 1205-1209, 1998 | 167 | 1998 |
| Italian, multicenter, phase III, randomized study of cisplatin plus etoposide with or without bevacizumab as first-line treatment in extensive-disease small-cell lung cancer … M Tiseo, L Boni, F Ambrosio, A Camerini, E Baldini, S Cinieri, M Brighenti, ... Journal of Clinical Oncology 35 (12), 1281-1287, 2017 | 164 | 2017 |
chiara cremoliniFull Professor, University of PisaVerified email at unipi.it
